PKU HealthCare Corp.,Ltd. (SHE:000788)
China · Delayed Price · Currency is CNY 5.48
-0.15 (-2.66%)
Sep 10, 2026, 3:04 PM CST
PKU HealthCare Corp.,Ltd. Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 972.17 | 1,482 | 2,060 | 2,194 | 2,077 | 2,237 |
Revenue Growth | -51.61% | -28.04% | -6.10% | 5.61% | -7.13% | 13.12% |
Gross Profit Gross Profit Growth | 323.03 | 410.96 | 531.27 | 711.92 | 772.12 | 908.96 |
Operating Income Operating Income Growth | 111.17 | 162.3 | 194.51 | 98.21 | 93.84 | 100.88 |
Net Income Net Income Growth | 38.26 | 82.88 | 137.99 | 44.36 | 55.61 | 43.14 |
Earnings Per Share EPS Growth | 0.06 | 0.14 | 0.23 | 0.07 | 0.09 | 0.07 |
EPS Growth | -74.74% | -39.93% | 211.16% | -20.26% | 28.87% | 3.43% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 622.53 | 623.13 | 768 | 770.7 | 883.38 |
Sale of medicines, reagents, medical equipment Sale of medicines, reagents, medical equipment Growth | 859.87 | 1,437 | 1,426 | 1,307 | 1,353 |
Offset of Business Segment Offset of Business Segment Growth | -0.02 | - | - | - | - |
Total Total Growth | 1,482 | 2,060 | 2,194 | 2,077 | 2,237 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,030 | 909.3 | 617.33 | 457.25 | 633.52 | 413.92 |
Total Debt Total Debt Growth | 88.94 | 23.11 | 63.63 | 82.14 | 191.21 | 354.2 |
Net Cash (Debt) Net Cash Growth | 940.97 | 886.19 | 553.7 | 375.12 | 442.31 | 59.71 |
Net Cash Growth | 70.18% | 60.05% | 47.61% | -15.19% | 640.72% | -73.06% |
Net Cash Per Share Net Cash Per Share Growth | 1.58 | 1.49 | 0.93 | 0.63 | 0.74 | 0.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 606.54 | 387.29 | 347.75 | 121.84 | 278.9 | 59.14 |
Capital Expenditures CapEx Growth | -34.32 | -48.77 | -39.37 | -63.2 | -35.32 | -45.4 |
Free Cash Flow Free Cash Flow Growth | 572.22 | 338.53 | 308.38 | 58.65 | 243.57 | 13.74 |
Free Cash Flow Growth | 110.97% | 9.77% | 425.83% | -75.92% | 1672.43% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 33.23% | 27.72% | 25.79% | 32.45% | 37.17% | 40.64% |
Operating Margin | 11.43% | 10.95% | 9.44% | 4.48% | 4.52% | 4.51% |
Pretax Margin | 4.91% | 6.93% | 8.37% | 3.39% | 3.40% | 2.77% |
Profit Margin | 3.94% | 5.59% | 6.70% | 2.02% | 2.68% | 1.93% |
FCF Margin | 58.86% | 22.84% | 14.97% | 2.67% | 11.72% | 0.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.198 | 0.198 | 0.080 | 0.026 | - | 0.023 |
Dividend Per Share Growth | 0% | 147.50% | 207.69% | - | - | - |
Dividend Yield | 3.52% | 3.33% | 1.38% | 0.41% | - | 0.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 87.71 | 43.94 | 25.91 | 90.16 | 79.74 | 94.63 |
Forward PE | - | 61.29 | 61.29 | 61.29 | 61.29 | 61.29 |
P/FCF Ratio | 5.86 | 10.76 | 11.60 | 68.19 | 18.20 | 297.08 |
PS Ratio | 3.45 | 2.46 | 1.74 | 1.82 | 2.13 | 1.83 |